Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-136481

Chief Financial Officer bought 24,000 shares at $0.69 ($16,550)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wood Gavin Chief Financial Officer 2020-12-14 Purchase +24,000 $0.69 $16,550 57,000 D
Open-market purchases · 24,000 sh · avg $0.69 · $16,550
Loading xslF345X03/tm2038497-2_4seq1.xml…